# OnCo record paper-atchley-brca-status-triple-negative-jco-2008 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-atchley-brca-status-triple-negative-jco-2008/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-atchley-brca-status-triple-negative-jco-2008" ;
  schema:name "Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer"@en ;
  schema:description "A 2008 MD Anderson series showing that 57 percent of breast cancers in BRCA1 carriers were triple-negative against 14 percent in women without a BRCA fault, the clinical number behind the rule that triple-negative diagnosis should prompt a genetic test."@en ;
  schema:url <https://onco.cc/key-papers/paper-atchley-brca-status-triple-negative-jco-2008/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2008.16.6231>, <https://pubmed.ncbi.nlm.nih.gov/18779615/> ;
  onco:tag "tnbc-evidence" ;
  schema:sameAs <https://doi.org/10.1200/JCO.2008.16.6231> ;
  schema:datePublished "2008"^^xsd:gYear ;
  schema:author "Atchley DP, Albarracin CT, Lopez A, et al." ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/germline-testing/> ;
  onco:targets <https://onco.cc/targets/brca/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:terms <https://onco.cc/technologies/germline-testing/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-hereditary-risk/> ;
  onco:journals <https://onco.cc/journals/jco/> .